$BIIB Company News Utility stocks gain as Treasury yields

New Post Public Reply Private Reply Replies (0) Message Board

Feb 13, 2014 at 11:50 AM

$BIIB Company News

Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 2:02 p.m. Jan. 29, 2014 - blogs.marketwatch.com
Biogen profit jumps on MS treatment revenue 7:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 8:00 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro

Isis to get another $9M from Biogen 9:15 a.m. Today - Seeking Alpha
What Makes Genomic Health (GHDX) a Strong Sell? - Tale of the Tape 8:45 a.m. Today - Zacks.com
Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 5:00 p.m. Feb. 12, 2014 - TheStreet.com
Drugs Stocks On The Rise With Help From 5 Stocks 12:02 p.m. Feb. 12, 2014 - TheStreet.com
Biotech Stock Roundup: Gilead's Sovaldi Impresses, EU Nod for Biogen's Tecfidera - Analyst Blog 8:27 a.m. Feb. 12, 2014 - Zacks.com
Data on Repros' Androxal - Analyst Blog 6:26 p.m. Feb. 11, 2014 - Zacks.com
NewLink Genetics (NLNK) Jumps: Stock Rises 8.3% - Tale of the Tape 9:21 a.m. Feb. 11, 2014 - Zacks.com
Sunesis Pharmaceuticals (SNSS) Falls: Stock Goes Down 5.4% - Tale of the Tape 8:58 a.m. Feb. 11, 2014 - Zacks.com
Scary, Overpriced Market? Here's 20 Odds-On Winners 5:44 a.m. Feb. 11, 2014 - Seeking Alpha
Puma Biotech Surges on Favorable Patent Ruling - Analyst Blog 5:35 p.m. Feb. 10, 2014 - Zacks.com
Gap-Ups Point To Strength Among Select Big Caps 4:35 p.m. Feb. 10, 2014 - Investors Business Daily
Affymetrix Slips to Hold - Analyst Blog 3:30 p.m. Feb. 10, 2014 - Zacks.com
Why You Need to Pay Attention to Cambrex Corporation. (CBM) Stock? - Tale of the Tape 8:59 a.m. Feb. 10, 2014 - Zacks.com
Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) 8:13 a.m. Feb. 10, 2014 - Benzinga.com
Worried About A Market Meltdown? Consider This. 3:08 a.m. Feb. 10, 2014 - Seeking Alpha
Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS 9:02 p.m. Feb. 9, 2014 - GuruFocus.com
EU Approval Widens Reach For Biogen Drug 5:31 p.m. Feb. 7, 2014 - Investors Business Daily
FDA to Review Spectrum Pharma' Beleodaq - Analyst Blog 5:00 p.m. Feb. 7, 2014 - Zacks.com
Biogen Idec (BIIB) On Momo Momentum Watch Today 11:59 a.m. Feb. 7, 2014 - TheStreet.com
Teva Beats on Q4 Earnings & Revs, Affirms View - Analyst Blog 9:10 a.m. Feb. 7, 2014 - Zacks.com

Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Today - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine 8:40 a.m. Feb. 3, 2014 - BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia 1:00 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion 6:30 a.m. Jan. 29, 2014 - BusinessWire - BZX
RBCC Develops Innovations in White-Hot 3D Bioprinting Sector 4:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver 9:31 a.m. Jan. 24, 2014 - PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Slide Stainers Market Reaches $7.39B Forecast By 2031

Slide Stainers Market Growth: A Closer Look In a world where precision and speed define medical success, the Slide Stainers Market is the silent hero no one talks about at cocktail parties. But make no mistake, its forecasted growth to $7.39 billion by 2031 shouts volumes in boardrooms and labs alike. With a modest start at $5.15 billion in 2026, this market is expected...

Koozee Boosts Apparel Design with AI Workflows

Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...

Ajman Media Forum 2026: Shaping the Future of Media

Kicking Off Ajman's Media Innovation Push Forget the stale conferences; Ajman is putting its chips on the table with the inaugural Ajman Media Forum 2026. Set to ignite on November 18 and 19 under the catchy theme 'Who Owns the Signal?,' this two-day brain fest takes media transformation by the horns. They're not just talking; they're set to weave emerging tech,...

PSG's Anna AI Wins Vizient's Innovative Tech Nod

Hospital Hiring Gets a Tech Boost In the bustling world of healthcare recruitment, it's like trudging through quicksand with a time bomb strapped to your back. That's where PSG Global Solutions sauntered into the Las Vegas spotlight with Anna AI, their generative AI marvel that just snagged the Innovative Technology designation from Vizient. This ain’t your...

ABCmouse Teams with Netflix for Global Learning Expansion

ABCmouse Reinvents Learning in a Digital Age Just when you thought the kids’ education scene couldn’t get any tech-savvier, ABCmouse swoops in with a new game changer. In collaboration with Netflix, the folks at Age of Learning have launched a slick mobile game that’ll keep the kiddies learning in the palm of their hands. Screen time just turned into brain-building...

Edera's New AI Security Strategy: A Game-Changer?

Shaking Up AI Security, Edera-Style In the world of artificial intelligence, there's always a new twist 'round the corner that makes the tech folks tingle—and Edera just served one up piping hot. This time, we're talking about a security revamp that sidesteps the age-old problem of giving AI agents too much rope to hang themselves. Forget about flinging open the keys to...

Coinhub Funded's Bold Move in Trading World

A New Name in the Trading Game Right out of Charlestown, Saint Kitts and Nevis, Coinhub Funded is making waves in the crypto prop trading world, and boy, they're not pulling any punches. They've just thrown their hat in the ring with a tantalizing offer: get your hands on a funded trading account up to $200K, and if that's not enough to get your pulse racing, they've got...

Netcapital Faces Fraud Lawsuit: Investor Impacts Unravel

Investors Caught in Netcapital's Storm Well, here we are, back on the wild roller coaster that is the stock market, and boy, has Netcapital Inc. landed itself in a mess. The company's been hit with a securities fraud class action lawsuit thanks to allegedly cooking up fake consulting agreements that padded their revenues by a cool $14 million. That’s not just pocket...

Sempra Shines with Robust Q3 2026 Financials

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Zhejiang Sets Eyes on Leading AI Innovation Frontier

AI Transformation: Zhejiang's Ambitious Trajectory Not too often does a province aim to shake up an industry like Zhejiang is doing with artificial intelligence. Local workshops, labs, and dailies are already seeing a drastic shift, courtesy of AI pushing the boundaries of possibility. A Financial Powerhouse: By the Numbers Grab a calculator because Zhejiang isn't messing...